Germline Variation Predicts Treatment Response in Multiple Myeloma

被引：0

作者：

Roter, Kyle ^{[1
]}

Hu, Donglei ^{[1
]}

Clay-Gilmour, Alyssa ^{[2
]}

Huntsman, Scott ^{[1
]}

Shah, Nina D. ^{[1
]}

Wong, Sandy W. ^{[1
]}

Martin, Thomas G., III ^{[1
]}

Wolf, Jeffrey Lee ^{[1
]}

Binder, Moritz ^{[3
]}

Kumar, Shaji K. ^{[4
]}

Rajkumar, S. Vincent ^{[3
]}

Slager, Susan L. ^{[4
]}

Vachon, Celine M. ^{[5
]}

Ziv, Elad ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

[2] Univ South Carolina, Columbia, SC 29208 USA

[3] Mayo Clin, Div Hematol, Rochester, MN USA

[4] Mayo Clin, Rochester, MN USA

[5] Mayo Clin, Div Epidemiol, Rochester, MN USA

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-129344

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4397

引用

页数：3

共 50 条

[21] Early Paraprotein Kinetics and Response to Treatment in Multiple Myeloma
Moritz, Binder
Rajkumar, S. Vincent
Lacy, Martha Q.
Gertz, Morie A.
Buadi, Francis K.
Dispenzieri, Angela
Hwa, Yi L.
Fonder, Amie
Hobbs, Miriam
Hayman, Suzanne R.
Zeldenrust, Steven
Lust, John A.
Russell, Stephen J.
Leung, Nelson
Kapoor, Prashant
Go, Ronald S.
Gonsalves, Wilson I.
Kourelis, Taxiarchis
Warsame, Rahma
Kyle, Robert A.
Kumar, Shaji K.
BLOOD, 2017, 130
[22] IS A DEEP RESPONSE THE KEY TO SUCCESSFUL TREATMENT OF MULTIPLE MYELOMA?
Liwing, J.
Heeg, B. M.
Karstorp, S.
Postma, M.
Silvennoinen, R.
Putkonen, M.
Anttila, P.
Remes, K.
Abildgaard, N.
Waage, A.
Nahi, H.
HAEMATOLOGICA, 2015, 100 : 92 - 92
[23] Risk and Response-Adapted Treatment in Multiple Myeloma
Cazaubiel, Titouan
Mulas, Olga
Montes, Lydia
Schavgoulidze, Anais
Avet-Loiseau, Herve
Corre, Jill
Perrot, Aurore
CANCERS, 2020, 12 (12) : 1 - 16
[24] The Role of NOXA in Venetoclax Treatment Response in Multiple Myeloma
Shivaram, Suganti
Yan, Huihuang
Tang, Hongwei
Anderson, Hans M.
Kaddoura, Marcella
Wiedmeier-Nutor, J. Erin
Tian, Shulan
Howe, Michael
Bolarinwa, Abiola
Mendoza, Cinthya Zepeda
Gupta, Vikas A.
Lehman, Stacey
Mitsiades, Constantine S.
Bergsagel, P. Leif
Braggio, Esteban
Boise, Lawrence H.
Fonseca, Rafael
Maura, Francesco
Kumar, Shaji
Baughn, Linda B.
BLOOD, 2024, 144
[25] TREATMENT RESPONSE IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA PATIENTS
Ioana, I.
Liviu, C.
Maria, C.
Claudiu, I.
Maria, I.
Mihai, I.
Dacian, O.
Ovidiu, P.
Cristina, S.
Despina, C.
Hortensia, I.
HAEMATOLOGICA, 2013, 98 : 614 - 614
[26] Computational Modeling of Protein Networks Predicts Treatment Outcomes in Multiple Myeloma (MM)
Drusbosky, Leylah M.
Murthy, Hemant S.
Leather, Helen L.
Grover, Himanshu
Narvekar, Yugandhara
Kumari, Pallavi
Narayanabhatia, Sirisha
Bhowmick, Priyanka
Abbasi, Taher
Vali, Shireen
Zhang, Qing
Usmani, Saad Z.
Cogle, Christopher R.
BLOOD, 2017, 130
[27] Germline Risk Contribution to Genomic Instability in Multiple Myeloma
Janz, Siegfried
Zhan, Fenghuang
Sun, Fumou
Cheng, Yan
Pisano, Michael
Yang, Ye
Goldschmidt, Hartmut
Hari, Parameswaran
FRONTIERS IN GENETICS, 2019, 10
[28] Characterization of Rare Germline Variants in Familial Multiple Myeloma
Catalano, Calogerina
Blocka, Joanna
Huhn, Stefanie
Paramasivam, Nagarajan
Schlesner, Matthias
Weinhold, Niels
Sijmons, Rolf
Langer, Christian
Preuss, Klaus
Durie, Brian G. M.
Nilsson, Bjorn
Goldschmidt, Hartmut
Bandapalli, Obul Reddy
Hemminki, Kari
Forsti, Asta
BLOOD, 2020, 136
[29] Characterization of rare germline variants in familial multiple myeloma
Catalano, Calogerina
Paramasivam, Nagarajan
Blocka, Joanna
Giangiobbe, Sara
Huhn, Stefanie
Schlesner, Matthias
Weinhold, Niels
Sijmons, Rolf
de Jong, Mirjam
Langer, Christian
Preuss, Klaus-Dieter
Nilsson, Bjorn
Durie, Brian
Goldschmidt, Hartmut
Bandapalli, Obul Reddy
Hemminki, Kari
Foersti, Asta
BLOOD CANCER JOURNAL, 2021, 11 (02)
[30] Pathogenic germline mutations in a large cohort of multiple myeloma
Fang, Teng
Sun, Hao
Hao, Mu
Qiu, Lugui
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S68 - S69

← 1 2 3 4 5 →